Results 91 to 100 of about 7,739 (166)
Arrhythmic effects of Ivabradine in patients with coronary artery disease
, 2009 Objectives: Ivabradine is the first specific heart rate-lowering agent that has completed clinical development for stable angina pectoris. The aim of the present study was to investigate the effects of ivabradine therapy on P-wave duration, dispersion ...
Orcan, Salih +5 more
core +3 more sources
The clinical and economic efficiency of treatment in patients with chronic heart failure
КардиоСоматика, 2013 Objective: to study the clinical and economic benefits of adding ivabradine to standard therapy for chronic heart failure (CHF). Subjects and methods.
E. I Tarlovskaya, S. V Malchikova
doaj
Rambam Maimonides Medical Journal, 2015 Background: Postural tachycardia syndrome (POTS) is a common form of chronic orthostatic intolerance. The remarkable increase in heart rate (HR) upon standing is the hallmark of this syndrome.
Merav Barzilai, Giris Jacob
doaj +1 more source
Российский кардиологический журнал, 2018 The review is focused on the role of ivabradine in percutaneous coronary intervention (PCI) and coronary bypass grafting (CBG) in coronary heart disease patients (CHD) with stable angina.
D. M. Aronov, M. G. Bubnova
doaj +1 more source
Ivabradine Use and Exercise Capacity Post-Atrial Switch Repair for Transposition of Great Arteries
JACC: AdvancesBackground: There are few proven therapies for improving exercise capacity in patients with transposition of the great arteries who have undergone an atrial switch repair.
William M. Wilson, MBBS +7 more
doaj +1 more source
Pakistan Armed Forces Medical Journal, 2020 Objective: To compare mean heart rate reduction in Ivabradine and placebo group in left ventricular failure patients. Study Design: Quasi experimental study.
Safia Batool +5 more
doaj
Evaluation of Clinical outcomes of Generic versus Reference Ivabradine in Heart Failure Patients
Archives of Pharmaceutical Sciences Ain Shams University, 2020 Economic benefits associated with usage of generic drugs have been suggested to increase patients’ adherence to their medications and to improve patients’ health outcomes.
Hadeer Eid +5 more
doaj
Ivabradine in acute coronary syndromes: Protection beyond heart rate lowering
, 2017 Ivabradine is a heart rate reducing agent that exhibits anti-ischemic effects through the inhibition of funny electrical current in the sinus node resulting in heart rate reduction, thus enabling longer diastolic perfusion time, and reduced myocardial ...
Crea, Filippo +9 more
core +1 more source
Clinical Implications of Ivabradine in the Contemporary Era
Ivabradine is a recently introduced inhibitor of the If ion channel, which exhibits the capacity to reduce heart rate while preserving hemodynamic stability.
Teruhiko Imamura
core +1 more source